aTYR PHARMA INC: cashflow_financing

Value{"amount": 21025000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-09-30
Statuscurrent
EntityaTYR PHARMA INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-24-123305 · Open the official SEC filing →
Retrieved: 2026-08-19T12:49:30.486433+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001339970/cashflow-financing/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a26ef2b6-a778-4ae9-9eb5-87b1b8944a2e

History

From the Record